©The Author(s) 2025.
World J Gastrointest Endosc. Oct 16, 2025; 17(10): 109031
Published online Oct 16, 2025. doi: 10.4253/wjge.v17.i10.109031
Published online Oct 16, 2025. doi: 10.4253/wjge.v17.i10.109031
Table 3 Adverse events, %
| Adverse event | ReShape Duo | Orbera | Obalon |
| Vomiting | 86.7 | 86.8 | 17.3 |
| Nausea | 61.0 | 75.6 | 56.0 |
| Abdominal pain | 54.5 | 57.5 | 72.6 |
| Gastric ulcer | 35.2 | 0.0 | 0.9 |
| Dyspepsia | 17.8 | 21.3 | 16.9 |
- Citation: Moutzoukis MK, Argyriou K, Manolakis A, Kapsoritakis A, Christodoulou D. Endoscopic bariatrics: Current status and emerging technologies. World J Gastrointest Endosc 2025; 17(10): 109031
- URL: https://www.wjgnet.com/1948-5190/full/v17/i10/109031.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i10.109031